<DOC>
	<DOCNO>NCT02521064</DOCNO>
	<brief_summary>Children Crohn 's disease effectively treat remain single-formula diet 8 continuous week . This dietary therapy know `` exclusive enteral nutrition '' ( EEN ) . It effective steroid treatment , 's traditionally used initial treatment Crohn 's disease . It clear EEN effective treat . One possibility change bacteria intestine , allow intestine heal . It also unclear whether EEN use treat ulcerative colitis , disease similar Crohn 's disease . The purpose research project determine whether EEN use treat ulcerative colitis , understand intestinal bacteria change EEN . Investigators compare result patient either Crohn 's disease ulcerative colitis , receive standard treatment disease ( steroid ) . This pilot study , mean goal study determine whether large study feasible . Investigators measure patient recruitment rate , whether patient able perform treatment request , whether safety concern , whether investigator able collect bloodwork stool sample without difficulty .</brief_summary>
	<brief_title>Effects Exclusive Enteral Nutrition Microbiome Pediatric Inflammatory Bowel Disease</brief_title>
	<detailed_description>Exclusive enteral nutrition ( EEN ) effective induction therapy pediatric Crohn 's disease ( CD ) . Compared corticosteroid , EEN equivalent rate clinical remission significantly high rate mucosal heal weight gain . There paucity literature role EEN ulcerative colitis ( UC ) . Some postulate colonic disease respond EEN , yet two series find difference rate clinical remission small intestinal colonic CD . The mechanisms underlying effectiveness enteral nutrition colitis remain unclear . A microbiome-mediated pathogenesis possible . Two study show EEN produce profound change microbial community structure within little 24 hour . These change correlate improved disease activity score . Active inflammatory bowel disease also carry distinct microbial signature . Baseline differences taxonomy IBD phenotype may account difference EEN efficacy CD UC . The purpose pilot study investigate EEN use induction remission ulcerative colitis , compare usage ) corticosteroids UC b ) EEN corticosteroids Crohn 's disease . The goal eventually characterize clinical , biochemical microbial change occur . However , give EEN challenge commitment , sole source nutrition 8 week , investigator first evaluate feasibility term participant recruitment , compliance safety treatment . Both EEN corticosteroid treatment require proper compliance effective , significant burden patient his/her family . Investigators therefore also determine satisfaction induction therapy effect quality life . Further , since frequent follow request , investigator need assess recruitment retention rate , well compliance complete bloodwork provide stool sample . Investigators hypothesize induction therapy feasible safe . However , anticipate , patient satisfy treatment , may significant impact quality life 8 week .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Children 518 year old diagnose IBD ( confirm endoscopy , histology radiography ) , follow McMaster Children 's Hospital 's Division Pediatric Gastroenterology Nutrition . Patients require induction therapy Patients already take 5aminosalicylic acid ( 5ASA ) azathioprine , 6mercaptopurine antiTNF ( tissue necrosis factor ) therapy ( e.g . infliximab ) Patients remission ( maintenance therapy ) . Patients receive new medical therapy ( e.g . antibiotic , probiotic ) study period</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>IBD</keyword>
	<keyword>enteral nutrition</keyword>
	<keyword>corticosteroid</keyword>
</DOC>